Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Uniklinikum Dresden, officially known as Universitätsklinikum Carl Gustav Carus Dresden, is a premier academic medical center and one of the largest healthcare providers in Germany. Affiliated with the Technische Universität Dresden, it serves as a central hub for supra-maximal medical care, advanced research, and medical education in the Free State of Saxony. The institution is globally recognized for its excellence in oncology, particularly through its role in the National Center for Tumor Diseases (NCT) and its state-of-the-art proton therapy facilities. Beyond cancer care, the hospital maintains a strong focus on metabolic disorders, neurology, and cardiovascular medicine, integrating clinical practice with high-impact translational research. It operates more than 20 specialized clinics and institutes, employing a workforce of approximately 8,000 professionals dedicated to patient care and innovation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Uniklinikum Dresden.